The Latest Cardiac and Vascular News
By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) When you think of precision medicine there are a few things that naturally come to mind: drugs tailored to genetics and certain other genome-based therapies. Medical devices are probably not your first thought. Earlier this year, Medtronic received approval for MR-Conditional Quadripolar Cardiac […]
Beleaguered Avinger, Inc. is slashing more jobs. In its latest financial disclosure, Avinger reported a 61 percent decline in sales since the same time last year and would continue its strategic reorganization to save cash. The company said headcount has been reduced to 73 employees as of Oct. 15. That number includes […]
Medtronic’s VenaSeal Closure System Receives New CPT Codes By Endovascular Today November 13, 2017—Medtronic has advised that their VenaSeal closure system received a favorable new CPT code as a Level 4 vascular procedure as part of the calendar year 2018 Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment and Ambulatory Surgical Center […]
VANCOUVER, Nov. 10, 2017 /PRNewswire/ – Neovasc Inc.(NASDAQ, TSX: NVCN) today announced that it will release its financial results for the third quarter 2017 on Tuesday, November 14, 2017, after markets close. The Company will subsequently hold a conference call that same day at 4:30 pm Eastern Time hosted by Mr. Alexei […]
Santa Monica, CA, Nov. 10, 2017 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced the appointment of Andrew Filler to the Company’s Board of Directors. […]
FRANKFURT – Siemens AG has replaced the chief financial officer of its Healthineers unit as it prepares to go public next year. This morning, Siemens announced that Jochen Schmitz, currently the head of accounting for the Siemens Group, will replace Thomas Rathmann on Dec. 1. Rathmann is leaving the Healthineers unit by mutual agreement, the company announced. Siemens praised […]
VANCOUVER, Nov. 9, 2017 /PRNewswire/ – Neovasc (Nasdaq: NVCN) today announced that it has priced an underwritten offering of 6,609,588 Series A units (the “Series A Units”) of Neovasc and 19,066,780 Series B units (the “Series B Units” and together with the Series A Units, the “Units”) of the Company, at a […]
ALAMEDA, Calif., Nov. 7, 2017 /PRNewswire/ — Penumbra, Inc.(NYSE: PEN), a global healthcare company focused on interventional therapies, today reported financial results for the third quarter ended September 30, 2017. Revenue of $83.9 million in the third quarter of 2017, an increase of 24.9%, or 24.1% in constant currency1, over the third quarter of 2016. […]
SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported financial results for the quarter ended September 30, 2017. Third Quarter 2017 Operating Results The Company initiated commercial sales of the Fantom bioresorbable scaffold […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the third quarter ended September 30, 2017. “Third quarter results were in line with our expectations, despite weather related disruptions,” commented John McDermott, Endologix’s Chief Executive Officer. “We are very […]
